Title:
PHARMACEUTICAL COMPOSITION FOR MASTITIS, AND MEDICAL TREATMENT METHOD
Document Type and Number:
WIPO Patent Application WO/2019/098241
Kind Code:
A1
Abstract:
Provided is a new pharmaceutical composition which is for mastitis and which is safe and has excellent handling properties and economic efficiency. This pharmaceutical composition for mastitis includes an ozone-dissolved glycerin and is applicable to the treatment of mastitis. A subject to be administered with this pharmaceutical composition for mastitis comprises, for example, humans, and non-human animals excluding humans, including milking animals such as cattle, goat, sheep, etc.
Inventors:
OKAMOTO YOSHIHARU (JP)
TSUKA TAKESHI (JP)
NISHIMURA RYO (JP)
HARADA KAZUKI (JP)
SHIOTA GOTARO (JP)
OKAMOTO AKIRA (JP)
OKAMOTO TARO (JP)
TSUKA TAKESHI (JP)
NISHIMURA RYO (JP)
HARADA KAZUKI (JP)
SHIOTA GOTARO (JP)
OKAMOTO AKIRA (JP)
OKAMOTO TARO (JP)
Application Number:
PCT/JP2018/042148
Publication Date:
May 23, 2019
Filing Date:
November 14, 2018
Export Citation:
Assignee:
MEDIPLUS PHARMA INC (JP)
NAT UNIV CORP TOTTORI UNIV (JP)
NAT UNIV CORP TOTTORI UNIV (JP)
International Classes:
A61K33/40; A61K9/06; A61K9/08; A61K47/02; A61K47/10; A61P15/14
Foreign References:
| JP2005232094A | 2005-09-02 | |||
| KR20010100340A | 2001-11-14 | |||
| JPH0677709U | 1994-11-01 |
Attorney, Agent or Firm:
TSUJIMARU Koichiro et al. (JP)
Download PDF: